Dynamic compression regulates the expression and synthesis of chondrocyte-specific matrix molecules in bone marrow stromal cells

Stem Cells

Volumn 25, Issue 3, 2007, Pages 655-663

  Mouw, Janna K ^a,b   Connelly, John T ^a,b   Wilson, Christopher G ^b   Michael, Kristin E ^a,b   Levenston, Marc E ^a,b,c  

^a GEORGIA INSTITUTE OF TECHNOLOGY   (United States)

^b GEORGIA INSTITUTE OF TECHNOLOGY   (United States)

^c Stanford University   (United States)

Author keywords

Chondrogenesis; Mechanical; Signal transduction; Stromal cells; Transforming growth factor

Indexed keywords

COLLAGEN TYPE 1; COLLAGEN TYPE 2; DEXAMETHASONE; GLYCOSAMINOGLYCAN POLYSULFATE; SMAD2 PROTEIN; SMAD3 PROTEIN; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL CELL; ARTICLE; BONE MARROW CELL; CELL VIABILITY; CHONDROGENESIS; CONTROLLED STUDY; DNA CONTENT; DYNAMICS; EXTRACELLULAR MATRIX; MECHANOTRANSDUCTION; NONHUMAN; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN SYNTHESIS;

ANIMALS; BONE MARROW CELLS; CATTLE; CELL SEPARATION; CELL SURVIVAL; DEXAMETHASONE; EXTRACELLULAR MATRIX; GENE EXPRESSION REGULATION; KINETICS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SMAD2 PROTEIN; SMAD3 PROTEIN; STROMAL CELLS; TRANSFORMING GROWTH FACTOR BETA;

BOVINAE;

EID: 33847613414     PISSN: 10665099     EISSN: None     Source Type: Journal    
DOI: 10.1634/stemcells.2006-0435     Document Type: Article

References (62)

1. Bruder SP, Fink DJ, Caplan AI. Mesenchymal stem cells in bone development, bone repair, and skeletal regeneration therapy. J Cell Biochem 1994;56:283-294.
2. Colnot C. Cellular and molecular interactions regulating skeletogenesis. J Cell Biochem 2005;95:688-697.
3. Cancedda R, Castagnola P, Cancedda FD et al. Developmental control of chondrogenesis and osteogenesis. Int J Dev Biol 2000;44:707-714.
4. Kadler K. Matrix loading: Assembly of extracellular matrix collagen fibrils during embryogenesis. Birth Defects Res C Embryo Today 2004;72:1-11.
5. Chiquet M, Matthisson M, Koch M et al. Regulation of extracellular matrix synthesis by mechanical stress. Biochem Cell Biol 1996;74:737-744.
6. Caplan AI, Bruder SP. Mesenchymal stem cells: Building blocks for molecular medicine in the 21st century. Trends Mol Med 2001;7:259-264.
7. Tuan RS, Boland G, Tuli R. Adult mesenchymal stem cells and cell-based tissue engineering. Arthritis Res Ther 2003;5:32-45.
8. Freed LE, Martin I, Vunjak-Novakovic G. Frontiers in tissue engineering. In vitro modulation of chondrogenesis. Clin Orthop Relat Res 1999;367(suppl):S46-S58.
9. Spagnoli A, Longobardi L, O'Rear L. Cartilage disorders: Potential therapeutic use of mesenchymal stem cells. Endocr Dev 2005;9:17-30.
10. Carter DR, Beaupre GS, Wong M et al. The mechanobiology of articular cartilage development and degeneration. Clin Orthop Relat Res 2004;427(suppl):S69-S77.
11. Roelen BA, Dijke P. Controlling mesenchymal stem cell differentiation by TGFBeta family members. J Orthop Sci 2003;8:740-748.
12. Pittenger MF, Mackay AM, Beck SC et al. Multilineage potential of adult human mesenchymal stem cells. Science 1999;284:143-147.
13. Mackay AM, Beck SC, Murphy JM et al. Chondrogenic differentiation of cultured human mesenchymal stem cells from marrow. Tissue Eng 1998;4:415-428.
14. Hall FL, Benya PD, Padilla SR et al. Transforming growth factor-beta type-II receptor signalling: Intrinsic/associated casein kinase activity, receptor interactions and functional effects of blocking antibodies. Biochem J 1996;316:303-310.
15. Frenkel SR, Saadeh PB, Mehrara BJ et al. Transforming growth factor beta superfamily members: Role in cartilage modeling. Plast Reconstr Surg 2000;105:980-990.
16. Grimaud E, Heymann D, Redini F. Recent advances in TGF-beta effects on chondrocyte metabolism. Potential therapeutic roles of TGF-beta in cartilage disorders. Cytokine Growth Factor Rev 2002;13:241-257.
17. Miyazono K. Positive and negative regulation of TGF-beta signaling. J Cell Sci 2000;113:1101-1109.
18. Moustakas A, Souchelnytskyi S, Heldin CH. Smad regulation in TGF-beta signal transduction. J Cell Sci 2001;114:4359-4369.
19. Nakao A, Imamura T, Souchelnytskyi S et al. TGF-beta receptor-mediated signalling through Smad2, Smad3 and Smad4. EMBO J 1997;16:5353-5362.
20. Mehra A, Wrana JL. TGF-beta and the Smad signal transduction pathway. Biochem Cell Biol 2002;80:605-622.
21. Yonekura A, Osaki M, Hirota Y et al. Transforming growth factor-beta stimulates articular chondrocyte cell growth through p44/42 MAP kinase (ERK) activation. Endocr J 1999;46:545-553.
22. Rosado E, Schwartz Z, Sylvia VL et al. Transforming growth factor-beta1 regulation of growth zone chondrocytes is mediated by multiple interacting pathways. Biochim Biophys Acta 2002;1590:1-15.
23. Hirota Y, Tsukazaki T, Yonekura A et al. Activation of specific MEK-ERK cascade is necessary for TGFbeta signaling and crosstalk with PKA and PKC pathways in cultured rat articular chondrocytes. Osteoarthritis Cartilage 2000;8:241-247.
24. Watanabe H, de Caestecker MP, Yamada Y. Transcriptional cross-talk between Smad, ERK1/2, and p38 mitogen-activated protein kinase pathways regulates transforming growth factor-beta-induced aggrecan gene expression in chondrogenic ATDC5 cells. J Biol Chem 2001;276:14466-14473.
25. Wakitani S, Goto T, Pineda SJ et al. Mesenchymal cell-based repair of large, full-thickness defects of articular cartilage. J Bone Joint Surg Am 1994;76:579-592.
26. Miyanishi K, Trindade MC, Lindsey DP et al. Effects of hydrostatic pressure and transforming growth factor-beta 3 on adult human mesenchymal stem cell chondrogenesis in vitro. Tissue Eng 2006;12:1419-1428.
27. Huang CY, Hagar KL, Frost LE et al. Effects of cyclic compressive loading on chondrogenesis of rabbit bone-marrow derived mesenchymal stem cells. STEM CELLS 2004;22:313-323.
28. Elder SH, Goldstein SA, Kimura JH et al. Chondrocyte differentiation is modulated by frequency and duration of cyclic compressive loading. Ann Biomed Eng 2001;29:476-482.
29. Elder SH, Kimura JH, Soslowsky LJ et al. Effect of compressive loading on chondrocyte differentiation in agarose cultures of chick limb-bud cells. J Orthop Res 2000;18:78-86.
30. Angele P, Schumann D, Angele M et al. Cyclic, mechanical compression enhances chondrogenesis of mesenchymal progenitor cells in tissue engineering scaffolds. Biorheology 2004;41:335-346.
31. Lipman JM. Fluorophotometric quantitation of DNA in articular cartilage utilizing Hoechst 33258. Anal Biochem 1989;176:128-131.
32. Farndale RW, Sayers CA, Barrett AJ. A direct spectrophotometric microassay for sulfated glycosaminoglycans in cartilage cultures. Connect Tissue Res 1982;9:247-248.
33. Enobakhare BO, Bader DL, Lee DA. Quantification of sulfated glycosaminoglycans in chondrocyte/alginate cultures, by use of 1,9-dimethylmethylene blue. Anal Biochem 1996;243:189-191.
34. Sah RL, Kim YJ, Doong JY et al. Biosynthetic response of cartilage explants to dynamic compression. J Orthop Res 1989;7:619-636.
35. Buschmann MD, Gluzband YA, Grodzinsky AJ et al. Chondrocytes in agarose culture synthesize a mechanically functional extracellular matrix. J Orthop Res 1992;10:745-758.
36. Knight MM, Ghori SA, Lee DA et al. Measurement of the deformation of isolated chondrocytes in agarose subjected to cyclic compression. Med Eng Phys 1998;20:684-688.
37. Lee DA, Knight MM, Bolton JF et al. Chondrocyte deformation within compressed agarose constructs at the cellular and sub-cellular levels. J Biomech 2000;33:81-95.
38. Hing WA, Sherwin AF, Poole CA. The influence of the pericellular microenvironment on the chondrocyte response to osmotic challenge. Osteoarthritis Cartilage 2002;10:297-307.
39. Evans RM. The steroid and thyroid hormone receptor superfamily. Science 1988;240:889-895.
40. Mangelsdorf DJ, Thummel C, Beato M et al. The nuclear receptor superfamily: The second decade. Cell 1995;83:835-839.
41. Shur I, Socher R, Benayahu D. Dexamethasone regulation of cFos mRNA in osteoprogenitors. J Cell Physiol 2005;202:240-245.
42. Kim H, Suh H, Jo SA et al. In vivo bone formation by human marrow stromal cells in biodegradable scaffolds that release dexamethasone and ascorbate-2-phosphate. Biochem Biophys Res Commun 2005;332:1053-1060.
43. Derfoul A, Perkins GL, Hall DJ et al. Glucocorticoids promote chondrogenic differentiation of adult human mesenchymal stem cells by enhancing expression of cartilage extracellular matrix genes. STEM CELLS 2006;24:1487-1495.
44. Locker M, Kellermann O, Boucquey M et al. Paracrine and autocrine signals promoting full chondrogenic differentiation of a mesoblastic cell line. J Bone Miner Res 2004;19:100-110.
45. Luettich K, Schmidt C. TGFbeta1 activates c-Jun and Erk1 via alphaV-beta6 integrin. Mol Cancer 2003;2:33.
46. You L, Kruse FE. Differential effect of activin A and BMP-7 on myofibroblast differentiation and the role of the Smad signaling pathway. Invest Ophthalmol Vis Sci 2002;43:72-81.
47. Wang SE, Wu FY, Shin I et al. Transforming growth factor beta (TGF-beta)-Smad target gene protein tyrosine phosphatase receptor type kappa is required for TGF-beta function. Mol Cell Biol 2005;25:4703-4715.
48. Furumatsu T, Tsuda M, Taniguchi N et al. Smad3 induces chondrogenesis through the activation of SOX9 via CREB-binding protein/p300 recruitment. J Biol Chem 2005;280:8343-8350.
49. Chen CW, Tsai YH, Deng WP et al. Type I and II collagen regulation of chondrogenic differentiation by mesenchymal progenitor cells. J Orthop Res 2005;23:446-453.
50. Sekiya I, Tsuji K, Koopman P et al. SOX9 enhances aggrecan gene promoter/enhancer activity and is upregulated by retinoic acid in a cartilage-derived cell line, TC6. J Biol Chem 2000;275:10738-10744.
51. Kypriotou M, Fossard-Demoor M, Chadjichristos C et al. SOX9 exerts a bifunctional effect on type II collagen gene (COL2A1) expression in chondrocytes depending on the differentiation state. DNA Cell Biol 2003;22:119-129.
52. Lefebvre V, Huang W, Harley VR et al. SOX9 is a potent activator of the chondrocyte-specific enhancer of the pro alpha1(II) collagen gene. Mol Cell Biol 1997;17:2336-2346.
53. Huang CY, Reuben PM, Cheung HS. Temporal expression patterns and corresponding protein inductions of early responsive genes in rabbit bone marrow-derived mesenchymal stem cells under cyclic compressive loading. STEM CELLS 2005;23:1113-1121.
54. Heldin CH, Miyazono K, ten Dijke P. TGF-beta signalling from cell membrane to nucleus through SMAD proteins. Nature 1997;390:465-471.
55. Massague J, Chen YG. Controlling TGF-beta signaling. Genes Dev 2000;14:627-644.
56. Lagna G, Hata A, Hemmati-Brivanlou A et al. Partnership between DPC4 and SMAD proteins in TGF-beta signalling pathways. Nature 1996;383:832-836.
57. Pedrozo HA, Schwartz Z, Robinson M et al. Potential mechanisms for the plasmin-mediated release and activation of latent transforming growth factor-beta1 from the extracellular matrix of growth plate chondrocytes. Endocrinology 1999;140:5806-5816.
58. George SJ, Johnson JL, Smith MA et al. Transforming growth factor-beta is activated by plasmin and inhibits smooth muscle cell death in human saphenous vein. J Vasc Res 2005;42:247-254.
59. Maeda S, Dean DD, Gay I et al. Activation of latent transforming growth factor beta1 by stromelysin 1 in extracts of growth plate chondrocyte-derived matrix vesicles. J Bone Miner Res 2001;16:1281-1290.
60. Tuli R, Tuli S, Nandi S et al. Transforming growth factor-beta-mediated chondrogenesis of human mesenchymal progenitor cells involves N-cadherin and mitogen-activated protein kinase and Wnt signaling cross-talk. J Biol Chem 2003;278:41227-41236.
61. Blanchette F, Rivard N, Rudd P et al. Cross-talk between the p42/p44 MAP kinase and Smad pathways in transforming growth factor beta 1-induced furin gene transactivation. J Biol Chem 2001;276:33986-33994.
62. Ungefroren H, Lenschow W, Chen WB et al. Regulation of biglycan gene expression by transforming growth factor-beta requires MKK6-p38 mitogen-activated protein kinase signaling downstream of Smad signaling. J Biol Chem 2003;278:11041-11049.